FDA urges stronger aspirin warning for late pregnancy
The FDA ordered tougher labels on over the counter aspirin to warn against use in the last three months of pregnancy unless directed by a physician. Manufacturers have one year to add the warning stating it may harm the unborn child or complicate delivery.
MENTIONED IN THIS ARTICLE
Washington
The
Food and Drug Administration
Lenapres
B&l Softspin
Also Mentioned on This Page
FDA
Federal Register
Pizza Brothers
Elyria Huran
Cleveland St. Commerce Plaza
Ene
Great Northern
North Dhagar
Randal
Plandal Pack
Mies Ave
J. Krause
Casper Rh
Byna
Medway
Larry Kreuse
Cleveland
Loran
Mentor
Amherst
Cooper Foster Park